Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 331 AL 345

Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?

Teich AF, Arancio O.

Biochem J. 2012 Sep 1;446(2):165-77. doi: 10.1042/BJ20120653.

Upregulated function of mitochondria-associated ER membranes in Alzheimer disease

Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJ, Madra M, Ikenouchi J, Umeda M, Bird TD, Sturley SL, Schon EA.

EMBO J. 2012 Nov 5;31(21):4106-23. doi: 10.1038/emboj.2012.202. Epub 2012 Aug 14.

Immunotherapy for Alzheimer's disease

Wang W, Fan L, Xu D, Wen Z, Yu R, Ma Q.

Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):807-14. doi: 10.1093/abbs/gms065. Epub 2012 Aug 16.

Greece reports prototype intervention with first peripherally inserted central catheter: case report and literature review

Konstantinou EA, Stafylarakis E, Kapritsou M, Mitsos AP, Fotis TG, Kiekkas P, Mariolis-Sapsakos T, Argyras E, Nomikou IT, Dimitrakopoulos A.

J Vasc Nurs. 2012 Sep;30(3):88-93. doi: 10.1016/j.jvn.2012.03.001.

A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease

Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, Donnelly JE, Billinger SA, Burns JM.

Contemp Clin Trials. 2012 Nov;33(6):1105-16. doi: 10.1016/j.cct.2012.08.002. Epub 2012 Aug 7.

Naturally occurring autoantibodies against β-Amyloid

Bach JP, Dodel R.

Adv Exp Med Biol. 2012;750:91-9. doi: 10.1007/978-1-4614-3461-0_7.

A new measure of caregiver burden in Alzheimer's disease: the caregiver-perceived burden questionnaire

Erder MH, Wilcox TK, Chen WH, O'Quinn S, Setyawan J, Saxton J.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):474-82. doi: 10.1177/1533317512456449. Epub 2012 Aug 16.

Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis

Irvine K, Laws KR, Gale TM, Kondel TK.

J Clin Exp Neuropsychol. 2012;34(9):989-98. doi: 10.1080/13803395.2012.712676. Epub 2012 Aug 23.

[Gamma-secretase inhibitors in Alzheimer's disease therapy]

Katarína S, Jan K, Kamil K, Kamil M.

Ceska Slov Farm. 2012 Jun;61(3):93-100.

Targeting synaptic dysfunction in Alzheimer's disease therapy

Nisticò R, Pignatelli M, Piccinin S, Mercuri NB, Collingridge G.

Mol Neurobiol. 2012 Dec;46(3):572-87. doi: 10.1007/s12035-012-8324-3. Epub 2012 Aug 23.

Alzheimer's and other dementias

Casey G.

Nurs N Z. 2012 Jul;18(6):20-4.

The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study

Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan DH, Potter JF.

Am J Geriatr Pharmacother. 2012 Oct;10(5):296-302. doi: 10.1016/j.amjopharm.2012.08.002. Epub 2012 Aug 22.

[Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease]

Więdłocha M, Stańczykiewicz B, Jakubik M, Rymaszewska J.

Postepy Hig Med Dosw (Online). 2012 Jun 22;66:415-30. doi: 10.5604/17322693.1001098.

Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies

Chow N, Aarsland D, Honarpisheh H, Beyer MK, Somme JH, Elashoff D, Rongve A, Tysnes OB, Thompson PM, Apostolova LG.

Dement Geriatr Cogn Disord. 2012;34(1):44-50. doi: 10.1159/000339727. Epub 2012 Aug 20.

[Mechanisms of neurodegeneration in Alzheimer's disease]

Jovanović Z.

Med Pregl. 2012 Jul-Aug;65(7-8):301-7. doi: 10.2298/mpns1208301j.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias